153 related articles for article (PubMed ID: 7591736)
1. Quality of life assessment among migraine patients treated with sumatriptan.
Solomon GD; Skobieranda FG; Genzen JR
Headache; 1995 Sep; 35(8):449-54. PubMed ID: 7591736
[TBL] [Abstract][Full Text] [Related]
2. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.
Lofland JH; Johnson NE; Batenhorst AS; Nash DB
Arch Intern Med; 1999 Apr; 159(8):857-63. PubMed ID: 10219932
[TBL] [Abstract][Full Text] [Related]
3. Improvements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
[TBL] [Abstract][Full Text] [Related]
4. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine.
Mushet GR; Miller D; Clements B; Pait G; Gutterman DL
Headache; 1996 Mar; 36(3):137-43. PubMed ID: 8984084
[TBL] [Abstract][Full Text] [Related]
5. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
GĂ©raud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the measurement of quality of life in migraine.
Solomon GD
Neurology; 1997 Mar; 48(3 Suppl 3):S10-5. PubMed ID: 9071264
[TBL] [Abstract][Full Text] [Related]
7. Using pretreatment quality of life perceptions to predict response to sumatriptan in migraineurs.
Litaker DG; Solomon GD; Genzen JR
Headache; 1997; 37(10):630-4. PubMed ID: 9439083
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes.
Smith T; Blumenthal H; Diamond M; Mauskop A; Ames M; McDonald S; Lener S; Burch S
Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
10. Effect of preventive treatment on health-related quality of life in episodic migraine.
Bordini CA; Mariano da Silva H; Garbelini RP; Teixeira SO; Speciali JG
J Headache Pain; 2005 Oct; 6(5):387-91. PubMed ID: 16362711
[TBL] [Abstract][Full Text] [Related]
11. Rizatriptan: a review of its efficacy in the management of migraine.
Dooley M; Faulds D
Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
[TBL] [Abstract][Full Text] [Related]
12. Effects of medication use on health state in postictal migraineurs.
Mulder EJ; Passchier J; Linssen WH; de Geus EJ
Headache; 2001 Sep; 41(8):782-91. PubMed ID: 11576203
[TBL] [Abstract][Full Text] [Related]
13. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies.
Winner P; Mannix LK; Putnam DG; McNeal S; Kwong J; O'Quinn S; Richardson MS
Mayo Clin Proc; 2003 Oct; 78(10):1214-22. PubMed ID: 14531480
[TBL] [Abstract][Full Text] [Related]
14. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
[TBL] [Abstract][Full Text] [Related]
15. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
[TBL] [Abstract][Full Text] [Related]
16. The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss.
Kwong WJ; Taylor FR; Adelman JU
J Occup Environ Med; 2005 Nov; 47(11):1167-73. PubMed ID: 16282878
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
Winner P; Ricalde O; Le Force B; Saper J; Margul B
Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]